Recursion Pharmaceuticals Inc Clas (RXRX)
SG&A Expenses
$151.41M
TTM · Period ending: · USD
RXRX SG&A Expenses
Latest reported$151.41Mperiod ending
Latest reported$151.41Mperiod ending
RXRX SG&A Expenses ($18.95M → $151.41M)
Annual SG&A Expenses
High-resolution chart · PNG
RXRX sg&a expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expenses (USD) |
|---|---|
| 176,589,000 | |
| 178,184,000 | |
| 110,822,000 | |
| 81,599,000 | |
| 57,682,000 | |
| 25,258,000 | |
| 18,951,000 |